Striatal Dopaminergic Reserve Shapes the Longitudinal Impact of Peripheral Immune Activation on Motor Progression in Parkinson's Disease
Osman Kahveci, Ulaş Ay, Tamer DemiralpAbstract
Background
Peripheral immune dysregulation has been implicated in Parkinson's disease (PD) progression, but whether motor deterioration reflects accelerated nigrostriatal degeneration or residual dopaminergic reserve remains unclear.
Objectives
To examine whether baseline and time‐varying neutrophil‐to‐lymphocyte ratio (NLR) relate to motor progression and striatal dopamine transporter (DAT) decline, and whether baseline DAT modifies the NLR–motor relationship.
Methods
We analyzed 7 years of Parkinson's Progression Markers Initiative (PPMI) data from 335 drug‐naive patients with PD and 305 healthy controls. Linear mixed‐effects models assessed NLR trajectories, longitudinal Unified Parkinson's Disease Rating Scale‐Part III (UPDRS‐III) and DAT associations, and moderation by baseline DAT; follow‐up motor assessments were ON‐medication.
Results
Conclusions
Higher baseline NLR predicted faster treated‐state motor worsening, while visit‐wise NLR tracked concurrent severity. These associations were not accompanied by clear evidence of accelerated DAT decline, supporting a reserve‐dependent relationship between peripheral inflammation and motor progression. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.